Skip to main content
padlock icon - secure page this page is secure

A large deletion of the repeat site in semenogelin I is not involved in male infertility

Buy Article:

$42.00 + tax (Refund Policy)

Semenogelin (Sg) is the major protein involved in gelatinous entrapment of ejaculated spermatozoa, which plays an important role on the regulation of sperm motility and fertilization. We investigated deletion in Sg-I and -II genomic genes with the objective of diagnosis of asthenozoospermia. As a result, heterozygous deletion of a repeat site in exon 2 of the Sg-I genomic gene was identified. The repeat site-deleted Sg-I protein was also detected together with full-sized Sg-I in semen ejaculated from infertile patients who were diagnosed as having the heterozygous deletion of a repeat site in exon 2 of the Sg-I genomic gene. However, the deletion was found not only in male infertile patients but also in fertile men. The deletion frequency was 1.1% in infertile patients and 2.8% in fertile men. The deletion was found to have no effect on testicular volume, endocrine hormone concentration and sperm quality. In addition, the wild-type, the repeat site-deleted and active site-deleted Sg-I proteins were produced in recombinant baculovirus-infected Sf21 cells and their seminal plasma motility inhibitor (SPMI) activities were determined. The repeat site-deleted Sg-I had similar SPMI activity to the full-sized Sg-I, while the active site-deleted Sg-I had almost lost SPMI activity. In conclusion, the deletion of a repeat site in the Sg-I genomic gene found in infertile patients and fertile men does not affect sperm quality and male infertility.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Affiliations: Department of Urology, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki 216-8511, Japan

Publication date: January 1, 2003

More about this publication?
  • The International Journal of Molecular Medicine is a monthly, peer-reviewed journal devoted to the publication of high quality studies related to the molecular mechanisms of human disease. The journal welcomes research on all aspects of molecular and clinical research, ranging from biochemistry to immunology, pathology, genetics, human genomics, microbiology, molecular pathogenesis, molecular cardiology, molecular surgery and molecular psychology.

    The International Journal of Molecular Medicine aims to provide an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more